Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
HUS-YHTYMÄ has floated a tender for Request for Information: Equipment and Reagents for the Analysis of Biological Drug Assays. The project location is Finland and the tender is closing on 11 Apr 2025. The tender notice number is 125124-2025, while the TOT Ref Number is 115299202. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Finland
Summary : Request for Information: Equipment and Reagents for the Analysis of Biological Drug Assays
Deadline : 11 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 115299202
Document Ref. No. : 125124-2025
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The aim of this request for information is to find out the availability of equipment and reagents for the analysis of biological drug assays. The procurement unit aims to obtain comprehensive information of equipment, reagents, supplies and/or instrumentation including maintenance service and technical support available. This information may be used in a possible future call for tenders. The equipment that fulfills the need should meet the following requirements: - Random access analyzer - Analyzer and reagents have a CE-IVD mark. If not, are these under the CE-IVDR process, and what is the estimated time for the CE-IVDR approval? - Quantitative analyses Mandatory analytes (to be analyzed with same analyzer): - Infliximab, concentration from serum (approximately 2500 samples per year) - Adalimumab, concentration from serum (approximately 1100 samples per year) - Vedolizumab, concentration from serum (approximately 500 samples per year) - Ustekinumab, concentration from serum (approximately 300 samples per year) Optional analytes (must be analyzed with same analyzer as mandatory analytes listed above): - Golimumab, concentration from serum (approximately 150 samples per year) - Golimumab anti-drug antibodies from serum (approximately maximum 50 per year). Specify, is this test measuring free anti-drug antibodies, total anti-drug antibodies, or are both assay types (free and total) available. - Infliximab anti-drug antibodies from serum (approximately 200 samples per year). Spe...
Document Type: Prior Information Notice
Reference Number: HUS 038-2025
Contract Type: supplies
Authority Type: ra
Doc Title: REQUEST FOR INFORMATION: Equipment and reagents for the analysis of biological drug assays
Dispatch Date: 2025-02-24
Publish Date: 2025-02-25
Submission Date: 2025-04-11
Documents
Procurement Documents for Finland
Access a comprehensive library of standard procurement documents specific to Finland. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Finland
Want To Bid in This Tender?
Get Local Agent Support in Finland and 60 More Countries.
View Tenders By
Sign in with Google